Guidance on protecting people defined on medical grounds as clinically extremely vulnerable from coronavirus (COVID-19) – previously known as ‘shielding’
Information for protecting people defined on medical grounds as extremely vulnerable from COVID-19.
This file may not be fully accessible.
Most people who were identified as CEV (Clinically Extremely Vulnerable) are now well protected after receiving their primary and booster vaccination doses. For most people who were CEV, you are no longer at substantially greater risk than the general population, and you are advised to follow the same guidance as everyone else on staying safe and preventing the spread of coronavirus (COVID-19), as well as any further advice you may have received from your doctor.
The Shielding Patient List closed on the 31March 2022 after the Minister for Health and Social Services announced on the 10 March 2022 that the Chief Medical Officer for Wales would write to everyone on the Shielding Patient List to inform them the Shielding Patient List would no longer be in place from the 1 April 2022.
Therefore, there is no longer separate guidance for people previously identified as CEV, although we recommend anyone with underlying health conditions takes care to avoid routine coughs, colds and other respiratory viruses.
If you have not yet received the COVID-19 vaccine, you should get vaccinated. Evidence indicates that completion of your primary course of COVID-19 vaccine (either 2 or 3 doses) provides very effective protection against hospitalisation. It usually takes around 2 to 3 weeks for your body to develop its protective response.
To maintain this high level of protection you should also get a booster vaccine for COVID-19 when offered. The booster programme is open to every adult who has had a second dose of the vaccine at least 3 months ago.
You should continue to follow the same guidance as the general public on staying safe and preventing the spread of COVID-19.
There remains a smaller number of people who, in spite of vaccination, are at higher risk of serious illness from COVID-19. This is due to a weakened immune system (immunosuppressed) or specific other medical conditions and requires enhanced protections such as those offered by antibody and antiviral treatments, additional vaccinations and potentially other non-clinical interventions. Read more information about COVID-19 treatments on GOV.WALES